Literature DB >> 15759212

Identifying candidate Hirschsprung disease-associated RET variants.

Grzegorz M Burzynski1, Ilja M Nolte, Agnes Bronda, Krista K Bos, Jan Osinga, Ivan Plaza Menacho, Bas Twigt, Saskia Maas, Alice S Brooks, Joke B G M Verheij, Charles H C M Buys, Robert M W Hofstra.   

Abstract

Patients with sporadic Hirschsprung disease (HSCR) show increased allele sharing at markers in the 5' region of the RET locus, indicating the presence of a common ancestral RET mutation. In a previous study, we found a haplotype of six SNPs that was transmitted to 55.6% of our patients, whereas it was present in only 16.2% of the controls we used. Among the patients with that haplotype, 90.8% had it on both chromosomes, which led to a much higher risk of developing HSCR than when the haplotype occurred heterozygously. To more precisely define the HSCR-associated region and to identify candidate disease-associated variant(s), we sequenced the shared common haplotype region from 10 kb upstream of the RET gene through intron 1 and exon 2 (in total, 33 kb) in a patient homozygous for the common risk haplotype and in a control individual homozygous for the most common nonrisk haplotype. A comparison of these sequences revealed 86 sequence differences. Of these 86 variations, 8 proved to be in regions highly conserved among different vertebrates and within putative transcription factor binding sites. We therefore considered these as candidate disease-associated variants. Subsequent genotyping of these eight variants revealed a strong disease association for six of the eight markers. These six markers also showed the largest distortions in allele transmission. Interspecies comparison showed that only one of the six variations was located in a region also conserved in a nonmammalian species, making it the most likely candidate HSCR-associated variant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15759212      PMCID: PMC1199373          DOI: 10.1086/429589

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.

Authors:  S Bolk; A Pelet; R M Hofstra; M Angrist; R Salomon; D Croaker; C H Buys; S Lyonnet; A Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Segregation at three loci explains familial and population risk in Hirschsprung disease.

Authors:  Stacey B Gabriel; Rémi Salomon; Anna Pelet; Misha Angrist; Jeanne Amiel; Myriam Fornage; Tania Attié-Bitach; Jane M Olson; Robert Hofstra; Charles Buys; Julie Steffann; Arnold Munnich; Stanislas Lyonnet; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2002-04-15       Impact factor: 38.330

Review 3.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

4.  A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.

Authors:  Salud Borrego; Fred A Wright; Raquel M Fernández; Nita Williams; Manuel López-Alonso; Ramana Davuluri; Guillermo Antiñolo; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

5.  Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR).

Authors:  Guido Fitze; Hella Appelt; Inke R König; Heike Görgens; Ulrike Stein; Wolfgang Walther; Manfred Gossen; Matthias Schreiber; Andreas Ziegler; Dietmar Roesner; Hans K Schackert
Journal:  Hum Mol Genet       Date:  2003-11-04       Impact factor: 6.150

6.  RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems.

Authors:  R M Hofstra; Y Wu; R P Stulp; P Elfferich; J Osinga; S M Maas; L Siderius; A S Brooks; J J vd Ende; V M Heydendael; R S Severijnen; K M Bax; C Meijers; C H Buys
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

7.  The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.

Authors:  Ben Davidson; Iris Goldberg; Liora Tell; Sophya Vigdorchik; Mark Baekelandt; Aasmund Berner; Gunnar B Kristensen; Reuven Reich; Juri Kopolovic
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 8.  ETS transcription factors: possible targets for cancer therapy.

Authors:  Tsuneyuki Oikawa
Journal:  Cancer Sci       Date:  2004-08       Impact factor: 6.716

9.  Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2.

Authors:  Grzegorz M Burzynski; Ilja M Nolte; Jan Osinga; Isabella Ceccherini; Bas Twigt; Saskia Maas; Alice Brooks; Joke Verheij; Ivan Plaza Menacho; Charles H C M Buys; Robert M W Hofstra
Journal:  Eur J Hum Genet       Date:  2004-08       Impact factor: 4.246

10.  Single nucleotide polymorphic alleles in the 5' region of the RET proto-oncogene define a risk haplotype in Hirschsprung's disease.

Authors:  M Sancandi; P Griseri; B Pesce; G Patrone; F Puppo; M Lerone; G Martucciello; G Romeo; R Ravazzolo; M Devoto; I Ceccherini
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

View more
  13 in total

1.  RET polymorphisms and the risk of Hirschsprung's disease in a Chinese population.

Authors:  Cuiping Liu; Lei Jin; Hui Li; Jintu Lou; Chunfen Luo; Xuewu Zhou; Ji-Cheng Li
Journal:  J Hum Genet       Date:  2008-07-08       Impact factor: 3.172

Review 2.  Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR).

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2018-09-14       Impact factor: 1.827

Review 3.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

Review 4.  Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Authors:  Robert O Heuckeroth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-04       Impact factor: 46.802

5.  A novel susceptibility locus for Hirschsprung's disease maps to 4q31.3-q32.3.

Authors:  A S Brooks; P A Leegwater; G M Burzynski; P J Willems; B de Graaf; I van Langen; P Heutink; B A Oostra; R M W Hofstra; A M Bertoli-Avella
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

Review 6.  Building a brain in the gut: development of the enteric nervous system.

Authors:  A M Goldstein; R M W Hofstra; A J Burns
Journal:  Clin Genet       Date:  2012-11-27       Impact factor: 4.438

7.  Fine mapping of the 9q31 Hirschsprung's disease locus.

Authors:  C S Tang; Y Sribudiani; X P Miao; A R de Vries; G Burzynski; M T So; Y Y Leon; B H Yip; J Osinga; K J W S Hui; J B G M Verheij; S S Cherny; P K H Tam; P C Sham; R M W Hofstra; M M Garcia-Barceló
Journal:  Hum Genet       Date:  2010-04-02       Impact factor: 4.132

8.  Genetic variants in RET and risk of Hirschsprung's disease in Southeastern Chinese: a haplotype-based analysis.

Authors:  Jinfa Tou; Li Wang; Li Liu; Ying Wang; Rong Zhong; Shengyu Duan; Weiguang Liu; Qixing Xiong; Qinglong Gu; Hong Yang; Hui Li
Journal:  BMC Med Genet       Date:  2011-02-25       Impact factor: 2.103

9.  RET and PHOX2B genetic polymorphisms and Hirschsprung's disease susceptibility: a meta-analysis.

Authors:  Chun-mei Liang; Dong-mei Ji; Xu Yuan; Ling-ling Ren; Juan Shen; Hai-yan Zhang
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

10.  RET variants and haplotype analysis in a cohort of Czech patients with Hirschsprung disease.

Authors:  Eliska Vaclavikova; Sarka Dvorakova; Richard Skaba; Lucie Pos; Vlasta Sykorova; Tereza Halkova; Josef Vcelak; Bela Bendlova
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.